Part D Plans Generally Include Drugs Commonly Used by Dual Eligibles: 2019
This report fulfills for 2019 the annual reporting mandate from the Patient Protection and Affordable Care Act (ACA). The ACA requires OIG to conduct a study of the extent to which formularies used by Medicare Part D plans include drugs commonly used by full benefit dual eligible individuals (i.e...